 |
||
|
Rosatom Scientists Developed Prototypes of Irridum-192-based Micro Sources for Brachytherapy Rosatom, PUBLISHED 29.11.2024 Experts from Reactor Materials Institute (IRM), a company within Rosatom's Scientific Division, have developed ionizing radiation sources based on iridium-192 for use in brachytherapy. The high-dose therapy using these sources is safe for patients and practitioners, while being effective in treating numerous malignant tumors, both intracavitary and interstitial. The uniqueness of Rosatom scientists' solution is the small size of the device. It consists of a needle irradiated in the IRM's research reactor and enclosed in a capsule. The capsule has a cable manufactured using specialized techniques and welded onto it. All these operations are performed remotely using a manipulator in a high-temperature chamber. "We have already developed prototypes. Now we are ready to deliver them to clinics for testing. We plan to get our product certified and registered as a medical device in 2025. Once we have all the necessary permits in place, we will launch the product in the Russian market and later the CIS market," said Denis Butakov, Head of the Radiation Technologies at IRM JSC. Topics: Nuclear medicine, Rosatom, Isotopes Other news: WANO appoints Jose Gago as its new Chair Effective on 1 March 2025. 415 nuclear units are operating in the world 63 units are under construction. Six reactors with a capacity of 55 MW each. |
Hero of the day 
Alexey Likhachev attended the launching ceremony of Chukotka nuclear icebreaker After the launch, construction of Chukotka will proceed in the water, with hull sections and machine-building components being fabricated. It is expected to be commissioned in 2026. INTERVIEW
Rosatom OPINION
AtomInfo.Ru |